Nemiralisib
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for Nemiralisib, covering 2019-06-03 to 2021-06-18. Get the full timeline:
Most recent: Clinical Trial Update: Safety, Pharmacokinetic (PK) and Pharmacodynamic (PD) Study of Repeat Doses of Inhaled Nemiralisib in Patients With APDS/PASLI [Phase 2]